A Phase I/II, Double-Blind, Placebo-Controlled Study Validating the Safety, Pharmacokinetics and Pharmacodynamic Profile of Sarconeos in Paediatric Patients with Duchenne Myopathy (MYODA-PK)
Phase of Trial: Phase I/II
Latest Information Update: 28 Mar 2018
At a glance
- Drugs Sarconeos (Primary)
- Indications Duchenne muscular dystrophy
- Focus Pharmacokinetics
- Acronyms MYODA-PK
- Sponsors Biophytis
- 28 Mar 2018 According to a Biophytis media release, this study could be launched in the second half of 2018.
- 23 Mar 2018 New trial record
- 20 Mar 2018 According to a Biophytis media release, this study is expected to begin in 2018 and data collected from this study will be used to assess dosage for the phase II/III clinical trial.